AQEMIA is a next-gen pharmatech company generating one of the world’s fastest-growing drug discovery pipeline. Their mission is to design fast innovative drug candidates for dozens of critical diseases.

Their differentiation lies in their unique quantum and statistical mechanics algorithms fueling a generative artificial intelligence to design novel drug candidates, with already several drug discovery successes in internal pipeline as well as in collaboration with Pharma companies.

–  Therapeutic areas: Oncology, Immunology, Inflammation, Central Nervous System, Metabolism

–  Based in: Paris (FRANCE)

–  Employees: 51 – 200

– Created in: 2019